Although APL diagnoses should be established on the basis of molecular genetic tests, the findings from the current study suggest that, besides the distinct immunophenotypes, other not frequently expressed myeloid antigens, including CD64 and CD9, can facilitate initial and prompt diagnoses of APL. The gene discussed is FCGR1A; the disease is acute promyelocytic leukemia.